Go Pro

MarketBeat Instant News Alerts

Radware logo with Computer and Technology background

Insider Selling: Radware (NASDAQ:RDWR) Insider Sells 750 Shares

Radware Ltd. (NASDAQ:RDWR - Get Free Report) insider Rivkah Goldriech sold 750 shares of the firm's stock in a transaction that occurred on Thursday, July 9th. The stock was sold at an average price of $32.00, for a total transaction of $24,000.00. Following the completion of the transaction, the insider directly owned 59,991 shares of the company's stock, valued at approximately $1,919,712. This trade represents a 1.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

NASDAQ:RDWR
Read Insider Selling: Radware (NASDAQ:RDWR) Insider Sells 750 Shares
Genesco logo with Retail/Wholesale background

Gregory Sandfort Buys 2,958 Shares of Genesco (NYSE:GCO) Stock

Genesco Inc. (NYSE:GCO - Get Free Report) Director Gregory Sandfort acquired 2,958 shares of the stock in a transaction that occurred on Thursday, July 9th. The shares were acquired at an average cost of $33.80 per share, with a total value of $99,980.40. Following the transaction, the director owned 29,172 shares in the company, valued at approximately $986,013.60. The trade was a 11.28% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website.

NYSE:GCO
Read Gregory Sandfort Buys 2,958 Shares of Genesco (NYSE:GCO) Stock
ProQR Therapeutics logo with Medical background

ProQR Therapeutics (NASDAQ:PRQR) CEO Boer Daniel Anton De Buys 150,000 Shares

ProQR Therapeutics N.V. (NASDAQ:PRQR - Get Free Report) CEO Boer Daniel Anton De bought 150,000 shares of the stock in a transaction that occurred on Thursday, July 9th. The stock was bought at an average price of $1.74 per share, with a total value of $261,000.00. Following the completion of the purchase, the chief executive officer directly owned 300,000 shares in the company, valued at $522,000. This represents a 100.00% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website.

NASDAQ:PRQR
Read ProQR Therapeutics (NASDAQ:PRQR) CEO Boer Daniel Anton De Buys 150,000 Shares
IperionX logo with Industrials background

Insider Buying: IperionX (NASDAQ:IPX) CEO Purchases 138,720 Shares

IperionX Limited Sponsored ADR (NASDAQ:IPX - Get Free Report) CEO Anastasios Arima bought 138,720 shares of IperionX stock in a transaction on Friday, July 10th. The shares were acquired at an average price of $3.58 per share, for a total transaction of $496,617.60. Following the completion of the acquisition, the chief executive officer owned 12,455,502 shares of the company's stock, valued at approximately $44,590,697.16. This represents a 1.13% increase in their position. The acquisition was disclosed in a filing with the SEC, which is accessible through this link.

NASDAQ:IPX
Read Insider Buying: IperionX (NASDAQ:IPX) CEO Purchases 138,720 Shares
IperionX logo with Industrials background

Insider Buying: IperionX (NASDAQ:IPX) Chairman Purchases 225,000 Shares of Stock

IperionX Limited Sponsored ADR (NASDAQ:IPX - Get Free Report) Chairman Todd Hannigan acquired 225,000 shares of the stock in a transaction on Friday, July 10th. The stock was bought at an average price of $3.58 per share, with a total value of $805,500.00. Following the completion of the acquisition, the chairman directly owned 26,333,334 shares of the company's stock, valued at $94,273,335.72. This trade represents a 0.86% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website.

NASDAQ:IPX
Read Insider Buying: IperionX (NASDAQ:IPX) Chairman Purchases 225,000 Shares of Stock
Caris Life Sciences logo with Services background

Insider Buying: Caris Life Sciences (NASDAQ:CAI) Director Acquires $990,080.00 in Stock

Caris Life Sciences, Inc. (NASDAQ:CAI - Get Free Report) Director Jon Halbert bought 68,000 shares of the company's stock in a transaction dated Friday, May 15th. The stock was acquired at an average price of $14.56 per share, for a total transaction of $990,080.00. Following the acquisition, the director directly owned 704,598 shares in the company, valued at $10,258,946.88. This trade represents a 10.68% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

NASDAQ:CAI
Read Insider Buying: Caris Life Sciences (NASDAQ:CAI) Director Acquires $990,080.00 in Stock

Trending News

All MarketBeat Instant News Alerts

IperionX logo with Industrials background

IperionX (NASDAQ:IPX) Chairman Purchases $1,077,000.00 in Stock

NASDAQ:IPX
Read IperionX (NASDAQ:IPX) Chairman Purchases $1,077,000.00 in Stock
Netflix logo with Consumer Discretionary background

Netflix (NASDAQ:NFLX) Given New $100.00 Price Target at Oppenheimer

NASDAQ:NFLX
Read Netflix (NASDAQ:NFLX) Given New $100.00 Price Target at Oppenheimer
MasTec logo with Construction background

TD Cowen Forecasts Strong Price Appreciation for MasTec (NYSE:MTZ) Stock

NYSE:MTZ
Read TD Cowen Forecasts Strong Price Appreciation for MasTec (NYSE:MTZ) Stock
Whitehawk Therapeutics logo with Manufacturing background

Whitehawk Therapeutics (NASDAQ:WHWK) Earns Outperform Rating from Analysts at Leerink Partners

NASDAQ:WHWK
Read Whitehawk Therapeutics (NASDAQ:WHWK) Earns Outperform Rating from Analysts at Leerink Partners
Whirlpool logo with Consumer Discretionary background

BNP Paribas Exane Begins Coverage on Whirlpool (NYSE:WHR)

NYSE:WHR
Read BNP Paribas Exane Begins Coverage on Whirlpool (NYSE:WHR)
West Pharmaceutical Services logo with Medical background

BNP Paribas Exane Begins Coverage on West Pharmaceutical Services (NYSE:WST)

NYSE:WST
Read BNP Paribas Exane Begins Coverage on West Pharmaceutical Services (NYSE:WST)
Spruce Biosciences logo with Medical background

Spruce Biosciences (NASDAQ:SPRB) Earns Buy Rating from Analysts at B. Riley Financial

NASDAQ:SPRB
Read Spruce Biosciences (NASDAQ:SPRB) Earns Buy Rating from Analysts at B. Riley Financial

NervGen Pharma (NASDAQ:NGEN) Now Covered by Leerink Partners

NASDAQ:NGEN
Read NervGen Pharma (NASDAQ:NGEN) Now Covered by Leerink Partners
Casey's General Stores logo with Retail/Wholesale background

Casey's General Stores (NASDAQ:CASY) Upgraded to Buy at Northcoast Research

NASDAQ:CASY
Read Casey's General Stores (NASDAQ:CASY) Upgraded to Buy at Northcoast Research
ME Group International logo with Industrials background

ME Group International H1 Earnings Call Highlights

LON:MEGP
Read ME Group International H1 Earnings Call Highlights
American Realty Investors logo with Finance background

American Realty Investors, Inc. (NYSE:ARL) Short Interest Update

NYSE:ARL
Read American Realty Investors, Inc. (NYSE:ARL) Short Interest Update
Pedevco logo with Energy background

Pedevco Corp. (NYSEAMERICAN:PED) Short Interest Update

NYSEAMERICAN:PED
Read Pedevco Corp. (NYSEAMERICAN:PED) Short Interest Update
CAMP4 Therapeutics logo with Medical background

CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Short Interest Up 229.0% in June

NASDAQ:CAMP
Read CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Short Interest Up 229.0% in June
BW LPG logo with Transportation background

BW LPG Limited (NYSE:BWLP) Short Interest Update

NYSE:BWLP
Read BW LPG Limited (NYSE:BWLP) Short Interest Update
TPG logo with Finance background

BMO Capital Markets Cuts TPG (NASDAQ:TPG) Price Target to $50.00

NASDAQ:TPG
Read BMO Capital Markets Cuts TPG (NASDAQ:TPG) Price Target to $50.00
StepStone Group logo with Finance background

BMO Capital Markets Has Lowered Expectations for StepStone Group (NASDAQ:STEP) Stock Price

NASDAQ:STEP
Read BMO Capital Markets Has Lowered Expectations for StepStone Group (NASDAQ:STEP) Stock Price
KKR & Co. Inc. logo with Finance background

KKR & Co. Inc. (NYSE:KKR) Price Target Cut to $112.00 by Analysts at BMO Capital Markets

NYSE:KKR
Read KKR & Co. Inc. (NYSE:KKR) Price Target Cut to $112.00 by Analysts at BMO Capital Markets
Varonis Systems logo with Computer and Technology background

Varonis Systems (NASDAQ:VRNS) Price Target Raised to $52.00

NASDAQ:VRNS
Read Varonis Systems (NASDAQ:VRNS) Price Target Raised to $52.00
Angi logo with Computer and Technology background

Citizens Jmp Reaffirms "Market Perform" Rating for Angi (NASDAQ:ANGI)

NASDAQ:ANGI
Read Citizens Jmp Reaffirms "Market Perform" Rating for Angi (NASDAQ:ANGI)
Tenable logo with Computer and Technology background

Barclays Issues Positive Forecast for Tenable (NASDAQ:TENB) Stock Price

NASDAQ:TENB
Read Barclays Issues Positive Forecast for Tenable (NASDAQ:TENB) Stock Price
Blue Owl Capital logo with Finance background

BMO Capital Markets Cuts Blue Owl Capital (NYSE:OWL) Price Target to $11.00

NYSE:OWL
Read BMO Capital Markets Cuts Blue Owl Capital (NYSE:OWL) Price Target to $11.00
Pfizer logo with Medical background

Pfizer (NYSE:PFE) Price Target Cut to $35.00 by Analysts at Guggenheim

NYSE:PFE
Read Pfizer (NYSE:PFE) Price Target Cut to $35.00 by Analysts at Guggenheim
Ares Management logo with Finance background

Ares Management (NYSE:ARES) Price Target Raised to $128.00 at BMO Capital Markets

NYSE:ARES
Read Ares Management (NYSE:ARES) Price Target Raised to $128.00 at BMO Capital Markets
PTC logo with Computer and Technology background

Barclays Cuts PTC (NASDAQ:PTC) Price Target to $150.00

NASDAQ:PTC
Read Barclays Cuts PTC (NASDAQ:PTC) Price Target to $150.00

Featured Articles and Offers

Alert Categories

All Alerts